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Abstract 
Background: Cell adhesion molecules (CAMs) play pivotal role in the development of the 
central nervous system (CNS) and have also been reported to play role in the 
pathophysiology of schizophrenia. Missense mutations in the CAMs genes might alter the 
binding of their ligands, increasing the vulnerability to develop schizophrenia.  
Methods: We selected 15 missense single nucleotide polymorphisms (SNPs) in the CAMs 
genes of the CNS reported in the Kyoto Encyclopedia of Genes and Genomes (KEGG) and 
examined their association with schizophrenia in 278 patients and 284 control subjects (first 
batch). We genotyped the positive SNPs in 567 patients and 710 control subjects (second 
batch) and in 635 patients and 639 control subjects (replication samples).  
Results: Genotypic and allelic distributions of rs2298033 in the ITGA8 gene between the 
schizophrenia and control groups were significantly different in both batches (p = 0.005, 
0.007, respectively). Gender-based analysis revealed that the allelic and genotypic 
distributions of rs2298033 in the ITGA8 were significantly different between the 
schizophrenia and control groups among females in both batches (p = 0.010, 0.011 and 
0.0086, 0.010, respectively) but not in males. Combine analysis revealed a more significant 
differences (p = 0.0032; 0.0035 and 0.0024; 0.0025, respectively), but not in the replication 
samples. The significant differences for rs2802808 of the NFASC gene were only observed in 
the female subgroups of the first batch.  
Conclusion: These results suggest that both ITGA8 might have gender-specific roles in the 
development of schizophrenia. Further replication and functional studies are required to 
confirm these findings. 
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1. Introduction 
Schizophrenia is a common disorder caused by both genetic diathesis and 
environmental factors, but its etiology is still unclear. Thus, diagnosis and treatment of 
schizophrenia are based only on clinical assessment of symptoms and the course of the 
disorder. Modern treatments of schizophrenia are far from being able to cure the disorder and 
just relieve the symptoms. Therefore, understanding the pathophysiological processes 
underlying schizophrenia is considered to be essential for the development of a reliable 
treatment for schizophrenia (Gaur et al., 2008).  
Changes in groups of molecules such as adhesion molecules, cytoskeletal proteins, 
neurotrophins, and cell signaling molecules have been observed in the brains of 
schizophrenia patients (Gaur et al., 2008; Maynard et al., 2001). Moreover, the genetic 
component of schizophrenia is reported to involve single nucleotide polymorphism (SNPs) 
that are not distributed randomly across the genome but are distributed across genes that 
share a common biological function or pathway (Lips et al., 2011). Therefore, rather than 
focusing on specific susceptibility loci, the study of schizophrenia should be broadened to 
collections of neuronal phenotypes (Costa et al., 2003), such as cell adhesion molecules 
(CAMs) in the central nervous system (CNS).   
CAMs play an important role in the maintenance and modulation of synaptogenic 
activity within neuronal circuitries (Giagtzoglou et al., 2009; Kriebel et al., 2011) and have 
been reported to be important in the pathophysiology of schizophrenia (Lips et al., 2011). 
They also play an important role in axonal/dendritic growth, synapse formation and plasticity, 
and neurotransmission (Nakamoto et al., 2004; Moresco et al., 2005; Robertson et al., 2006; 
Goh et al., 2008; Corvin, 2010; Myers and Gomez, 2011; O’Dushlaine et al., 2011). 
Schizophrenia is a neurodevelopmental disorder that involves aberrant brain wiring or 
disconnectivity due to synaptogenic alterations (Maynard et al., 2001; Corvin, 2010; Jones 
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and Murray, 1991; Honer, 1999; Kirov et al., 2005; Hildebrandt et al., 2009; Chan et al., 
2010a). The behavioral disturbances found in schizophrenia involve developmental disorders 
not only in neurons, but also in glial cells (Jones and Murray, 1991). Specific cell adhesion 
interactions between neurons, glial cell, and extra cellular matrices are critical for the 
appropriate migration and placement of cortical neurons (Stanco et al., 2009). Given their 
role in synaptogenesis, cortical placement, and neurotransmission, CAMs might play a role in 
the pathophysiology of schizophrenia.  
The CAMs pathway reported in the Kyoto Encyclopedia of Genes and Genomes 
(KEGG) database (Figure 1) has been reported to be associated with schizophrenia and 
bipolar disorders susceptibility in genome-wide association study (GWAS) populations 
(Corvin, 2010; O’Dushlaine et al., 2011). Amino acid changes in these CAMs might affect 
the protein function and contribute to the risk of developing psychiatric and neurologic 
disorders. In the present study, we examined the association between missense mutations in 
CAM genes in the CNS and schizophrenia. 
 
2. Materials and methods 
2.1. Subjects  
This study was approved by the Ethical Committee for Genetic Studies of Kobe 
University Graduate School of Medicine and the Ethics Committee of Genetics at the Niigata 
University School of Medicine. Informed consent was obtained from all participants for this 
study. All participants were of Japanese descent and were recruited in the Kobe city area or 
Niigata area, Japan. Kobe sample is consisted of two batches of subjects. The first 
schizophrenia group consisted of 278 unrelated patients (124 males; mean age ± SD, 48.4 ± 
10.5 years; 154 females: 51.7 ± 12.6 years). The first control group consisted of 284 
unrelated healthy volunteers (123 males; mean age ± SD, 44.0 ± 1 5. 6 y ears; 161 females: 
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51.2 ± 15.5 years). There were no significant differences in the gender and age distributions 
between the schizophrenia and the control groups (χ2 = 0.096, p = 0.757 and t = 1.793, df = 
560, p = 0.074; respectively). Two SNPs which showed significant association with 
schizophrenia in this pilot study were then genotyped in the second batch of subjects 
consisted of 567 schizophrenic patients (296 males; mean age ± SD, 53.4 ± 13.5 years; 271 
females; mean age ± S D, 54.3 ± 15.0 y ears) and 710 controls (334 males; mean age ± SD, 
52.5 ± 18.8 years; 376 females; mean age ± SD, 54.3 ± 15.0 years). There were no significant 
differences in the gender and age distribution between the schizophrenia and the control 
groups (χ2 = 3.4, p = 0.067 and t = 0.163, df = 1246, p = 0. 871; respectively). 
Our two batches of sample are not completely independent. Some patients recruited in 
the first batch are also recruited in the second batch. Therefore we replicated our experiments 
in another independent group of samples recruited in Niigata area, Japan. The group 
consisted of 635 schizophrenic patients (345 males; mean age ± SD, 39.8 ± 13 .4 years; 290 
females; mean age ± S D, 39.7 ± 14.5 years) and 639 controls ( 341 males; mean age ± SD, 
36.7 ± 9.5 years; 298 females; mean age ± SD, 40.2 ± 11.8 years). The gender proportion was 
not significantly different (χ2 = 0 .12, p = 0.730), although the age distribution was slightly 
different (t = 2.027, df = 1266, p = 0.043). 
Psychiatric assessment was conducted in each participant as previously described 
(Watanabe et al., 2006; Yoshida et al., 2012). In brief, the patients were diagnosed by at least 
two psychiatrists according to the DSM-IV criteria for schizophrenia on the basis of 
unstructured interviews and reviews of their medical records. None of the control subjects 
had present, past or family (up to first degree relatives) histories of psychiatric disorders or 
substance abuse (excluding nicotine dependence). All control subjects were interviewed and 
were screened for psychiatric disorders based on an unstructured interview by a psychiatrist. 
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2.2. SNPs selection and genotyping 
First we identified neural adhesion molecule gene in KEGG and consulted NCBI 
dbSNP (http://www.ncbi.nlm.nih.gov/sites/entrez?db=snp) to identify any missense 
mutations they carried. Among 30 neural adhesion molecule genes identified in KEGG, 14 
carried missense mutations according to NCBI dSNP (Supplementary Table 1). We then 
selected 15 missense mutations with minor allele frequencies of more than 3 % in the 
Japanese population (based on NCBI dbSNP database) and conducted an association study 
using our samples of schizophrenic patients and control subjects.  
For genotype determination, peripheral blood was drawn from the subjects and the 
leukocyte DNA was extracted. We used TaqMan assays (Applied Biosystems, Foster City, 
CA, U.S.A.) for genotyping. We selected pre-designed Taqman SNP genotyping assays from 
the Applied Biosystems database (http://www.appliedbiosystem.com) for all 15 SNPs 
examined. Genotyping was performed according to the protocol recommended by 
manufacturer. 
 
2.3. Data analysis 
Genotype distributions were examined for Hardy-Weinberg equilibrium (HWE) and 
the SNPs were examined for linkage disequilibrium (LD) with Haploview v 4.2 software 
(Barret et al., 2005) (http://www.broad.mit.edu/mpg/haploview/). Haploview was also used to 
determine allelic/haplotypic frequencies, as well as an association between SNPs or 
haplotypes and schizophrenia. Permutation tests based on 10,000 replications were performed 
to calculate corrected P values of allelic or haplotypic analyses for multiple comparisons by 
the Haploview software, if necessary. Genotype-based association was tested with Cochran–
Armitage test for trend. Odd ratios were calculated with the minor allele regarded as the risk 
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allele. Statistical significance was defined at P < 0.05. Power analysis was calculated with the 
program PS v2.1.31 (Dupont and Plummer, 1998).  
 
3. Results  
A nominally significant difference was observed for both genotypic and allelic 
distributions of rs2298033 in the ITGA8 gene between the schizophrenia and control groups 
(Cochran Armitage test for trend Z = 2.8, p = 0.005 and Chi square χ2 = 7.32, p = 0.007, 
respectively) (Table 1). Gender based analysis revealed only female population showed a 
difference (Cochran Armitage test for trend Z = 2.6, p = 0.010 and Chi square χ2 = 6.54, p = 
0.011, respectively; OR = 0.500; 95% CI = 0.292 – 0.857).  Gender-based analysis also 
revealed a significant difference in both genotypic and allelic distributions of rs2802808 in 
the NFASC gene in the female population (Cochran Armitage test for trend Z = 2.0, p = 
0.044 and Chi square χ2 = 4.5, p = 0.034, respectively) which was not observed in the 
analyses of all subjects (Table 2). However, the observed differences did not withstand 
correction for multiple comparisons. The genotypic and allelic distributions of the other 13 
SNPs examined were not significantly different between the control and schizophrenia 
groups, although these negative results might be due to a lack of power in the pilot study. The 
distributions of all 15 SNPs examined were in HWE for both the schizophrenia and control 
groups.  
In the second batch of subjects, the genotypic and allelic distributions of rs2298033 
remained significantly different in both overall subjects (Cochran Armitage test for trend Z = 
2.6, p = 0.0086 and Chi square χ2 = 6.6, p = 0.010, respectively) and the female subgroup 
(Cochran Armitage test for trend Z = 2.5, p = 0.0115 and Chi square χ2 = 6.4, p = 0.0114, 
respectively), but not the genotypic and allelic distributions of rs2802808. The differences 
withstood correction for multiple comparisons. Although we did not observed any significant 
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difference in the allelic nor genotypic distributions of the two SNPs in the Niigata sample, the 
combined analysis yielded in a more significant association between rs2298033 and 
schizophrenia in both overall subjects (Cochran Armitage test for trend Z = 2.9, p = 0.0032 
and Chi square χ2 = 8.5, p = 0.0035) and the female subgroup (Cochran Armitage test for 
trend Z = 3.0, p = 0.0024 and Chi square χ2 = 9.17, p = 0.0025). The differences withstood 
correction for multiple comparisons. The distributions of these two SNPs were in HWE in 
both the schizophrenia and control groups (Table 3).  
Six of the selected SNPs in the pilot study (rs2652098, rs2287926, rs309559, 
rs188703, rs160278, and rs160278) were located in the CSPG2 gene. Haplotypes analyses 
revealed that all but rs2652098 were in tight LD. No significant difference in the distributions 
of the haplotypes was observed between the schizophrenia and control groups (data not 
shown).  
 
4. Discussion  
Integrins are a superfamily of cell adhesion receptors that bind to extracellular matrix 
ligands, cell-surface ligands, and soluble ligands (Takada et al., 2007). Integrins have a 
heterodimeric structure consisting of non-covalently associated α and β subunit. ITGA8 
encodes the integrin α8 subunit.  The α8 subunit in the rat brain was found predominantly in 
neurons and was concentrated in the olfactory bulb, hippocampal formation, substantia nigra, 
ventral tegmental area, and superior olivary complex (Einheber et al., 1996). Its distribution 
in the human brain has not been investigated.  
Integrins have been implicated in the extracellular signaling involved in the 
development of the nervous system (Bossy et al., 1991; Chan et al., 2007, 2010b; Benoit et al., 
2009) and were shown to play pivotal roles in the placement of cortical neurons (Stanco et al., 
2009). Integrins interact with a large number of signaling molecules and have been 
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implicated in the CNS physiology underlying synaptic and behavioral plasticity (Moresco et 
al., 2005; Chan et al., 2003, 2010b; Chun et al., 2001; Kramar et al., 2002). Several types of 
memory and long term potentiation (LTP), which are frequently reported to be impaired in 
psychiatric and cognitive disorders, are reported to be modulated by integrins (Chan et al., 
2003, 2007). Amino acid changes due to missense mutations in ITGA8 might alter the 
binding of integrin-ligand complexes. Takada et al (2007) reported that small variations in the 
particular structure or charge of a ligand can strongly influence the binding affinity and the 
capacity of the integrins. These alterations might lead to the development of schizophrenia or 
protects individual against schizophrenia, depending on the site of the changes and the effect 
on the binding affinity.  
Our results suggest that the amino acid change in rs2298033 of the ITGA8 gene might 
have a protective role against schizophrenia (Table 1), particularly in females (Tables 2 and 
3). Rs2298033 (Ser577Phe) is an intolerant amino acid change that is reported to be 
deleterious (Ekwa-Ekoka et al., 2004). The change from serine (a hydrophilic amino acid) to 
phenylalanine (a hydrophobic amino acid) is a non conservative amino acid change, possibly 
resulting in a change of function of the protein, which appears to increase resistance to 
schizophrenia.  
The NFASC gene encodes neurofascin, an immunoglobulin adhesion molecule 
localized in the nodes of Ranvier. Neurofascin functions in nerve conduction, particularly in 
GABAergic synapses. GABAergic innervation in the cortical layer, in which neurofascin 
might play role (Kriebel et al., 2011), is reduced in schizophrenia (Kriebel et al., 2011; 
Devaux and Gow, 2008; Pillai-Nair et al., 2005). In our pilot study, rs2802808 of the NFASC 
gene was associated with schizophrenia in females. However, the association was not 
significant in the second batch samples (Table 2 and 3).  
12 
 
Predisposition to schizophrenia is thought to be caused by multiple mutations in genes 
in neural development pathways (Kirov et al., 2005; Hildebrandt et al., 2009; Walsh et al., 
2008). Therefore, it is very unlikely that amino acids changes in the ITGA8 and NFASC 
genes alone will suffice as predisposing factors towards schizophrenia. Mutations in these 
genes probably act in concert with other risk factors, both genetic and environmental factors.  
There is some evidence of gender differences in the CAMs pathway. Ponthieux et al. 
(2003) reported a sex difference in the serum levels of CAMs. Bramachari and Pahan (2010) 
reported gender-specific expression of integrin in T cells which they thought contribute to 
gender difference in the prevalence of multiple sclerosis. Begic et al. (2010) reported that 
short-term changes in female sex hormone levels could modulate expression of soluble 
CAMs. However, to our knowledge no reports have shown gender-specific effects of the 
CAMs pathway in neurodevelopment. Nevertheless our findings suggest that integrins might 
possess a gender-specific property, particularly in schizophrenia patients. Although the 
prevalence of schizophrenia is relatively similar for males and females, the onset of 
symptoms is earlier in males than in females (Chu et al., 1988, Castle et al., 1998). Our 
findings suggest that although the types of CAMs in neurons are not different between males 
and females, mutations in these genes might contribute to the different time of onset of 
schizophrenia between males and females. Further studies are needed to determine whether 
the mutated protein functions differently in males and females.  
We cannot fully rule out the possibility of a type Ι error due to our relatively small 
sample size. Because we did not examine SNPs in promoter region, we might have missed 
other functional SNPs possibly related to schizophrenia in CAMs genes. Due to a lack of 
power, our pilot study might not have been able to detect differences among the subjects and 
thus the SNPs were not examined in our second batch and replication samples. Nevertheless, 
CAMs might play significant roles in the development and pathophysiology of schizophrenia 
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and further studies are required to identify their roles. Functional mutations in these genes 
might uncover the true nature of the pathophysiology of schizophrenia. 
In conclusion, we found an association between one missense mutation in the ITGA8 
gene and schizophrenia in the Japanese population, particularly in females. The observed 
significant difference withstood correction for multiple. However, it would be interesting to 
do a further study with a larger sample size and a wider coverage of SNPs.  Our results 
support that of O’Dushlaine et al. (2011) which reported that mechanisms involved in cell 
adhesion may contribute broadly to neurodevelopmental psychiatric phenotypes. 
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Table 1 Associations of missense mutations in cell adhesion molecules with schizophrenia in the first batch of the sample  
(n control = 284, schizophrenia  = 278) 
Gene  Position SNPs
a
 
Amino acid 
changes 
Phen 
b
 
Genotype 
c
 Minor allele p values 
Odds ratio 
(95% CI) 
Power 
MM Mm mm Freq allele 
HWE 
d
 
gen  
e
 
allelic 
f
 
PTPRF chr 1 rs3748796 A/G CON 0.936 0.060 0.004 0.034 G 0.537 0.586 0.570  0.819 0.056 
  14028960   Tyr450Cys SCZ 0.948 0.048 0.004 0.028 
 
0.361     (0.412-1.630)   
NFASC chr 1 rs2802808 C/G CON 0.282 0.462 0.256 0.487 C 0.245 0.477 0.466 1.093 0.068 
  56455070   Ile971Met SCZ 0.246 0.488 0.265 0.510 
 
0.785     (0.860-1.389)   
CNTN2 chr 1 rs2275697  G/A CON 0.278 0.448 0.274 0.498 A 0.101 0.758 0.753 0.963 0.062 
  56516379   Ala145Thr SCZ 0.256 0.511 0.233 0.489 
 
0.824     (0.759-1.220)   
ITGAV chr 2 rs3738918 A/G CON 0.922 0.071 0.007 0.042 G 0.160 0.172 0.168 1.458 0.115 
  37720884    Ile359Val SCZ 0.879 0.121 0.000 0.061 
 
0.712     (0.850-2.501)   
CSPG2 chr 5 rs2652098  C/T CON 0.774 0.194 0.032 0.129 T 0.053 0.516 0.504 0.885 0.050 
  33402431   Ser300Leu SCZ 0.779 0.210 0.011 0.116 
 
1.000     (0.617-1.267)   
CSPG2 chr 5 rs2287926  G/A CON 0.731 0.217 0.051 0.160 A 0.513 0.594 0.581 1.096 0.055 
  33409767   Gly428Asp SCZ 0.680 0.294 0.026 0.173 
 
0.838     (0.792-1.517)   
CSPG2 chr 5 rs309559  A/G CON 0.272 0.466 0.261 0.495 A 0.299 0.707 0.708 0.956 0.050 
  33427728   Lys1516Arg SCZ 0.246 0.540 0.213 0.483 
 
0.229     (0.755-1.210)   
CSPG2 chr 5 rs188703  G/A CON 0.300 0.473 0.226 0.463 G 0.475 0.959 0.960 0.994 0.058 
  33428658   Arg1826His SCZ 0.265 0.548 0.188 0.461 
 
0.125     (0.785-1.259)   
CSPG2 chr 5 rs160278  T/A CON 0.269 0.470 0.261 0.496 A 0.357 0.897 0.899 0.985 0.052 
  33430083   Phe2301Tyr SCZ 0.228 0.559 0.213 0.493 
 
0.073     (0.778-1.246)   
CSPG2 chr 5 rs160277  G/T CON 0.311 0.457 0.232 0.461 A 0.211 0.652 0.652 1.056 0.050 
  33431990   Asp2937Tyr SCZ 0.257 0.537 0.206 0.474 
 
0.268     (0.834-1.338)   
NRCAM chr 7 rs6958498  C/G CON 0.746 0.226 0.029 0.142 G 0.328 0.404 0.383 1.159 0.082 
  45867456   Pro545Ala SCZ 0.720 0.239 0.041 0.160 
 
0.105     (0.832-1.614)   
  15689716   Ser577Phe SCZ 0.850 0.150 0.000 0.075 
 
0.410     (0.380-0.860)   
1
8 
20 
 
PVRL1 chr 11 rs7940667 A/C CON 0.869 0.127 0.004 0.067 
A
 1.000 0.754 0.753 1.077 0.051 
  23073060   Val361Gly SCZ 0.863 0.129 0.007 0.072 
 
0.813     (0.678-1.712)   
CDH2 chr 18 rs2289664  C/T CON 0.971 0.029 0.000 0.015 C 1.000 0.349 0.354 1.528 0.141 
  7021406   Asn845Ser SCZ 0.956 0.044 0.000 0.022 
 
1.000     (0.620-3.769)   
CDH2 chr 18 rs17445840  G/A CON 0.849 0.151 0.000 0.076 A 0.375 0.792 0.795 0.941 0.140 
  7082796   Ala118Thr SCZ 0.865 0.128 0.008 0.071 
 
0.778     (0.597-1.485)   
a
 SNP single nucleotide polymorphisms, SNP identification number and position are determined by NCBI dbSNP 
(http://www.ncbi.nlm.nih.gov/sites/entrez?db=snp gene build assembly GRCh37 37.1); 
b
 Phenotype, CON control, SCZ schizophrenia; 
c
 M Major allele, m 
minor allele; 
d
 HWE Hardy Weinberg equilibrium; 
e
 Genotypic p value, determined with Cochran Armitage test for trend; 
f
 allelic p value, determined with 
Chi square 
 
 
Table 2 Gender-based analysis of missense mutations in NFASC and ITGA8 in the first batch of the sample 
Gene SNPs 
a 
Sex Phen 
b Genotype 
c 
Allele 
c  p values Odds ratio  
(95% CI) MM Mm mm M m  HWE 
d 
gen 
e
  allelic 
f 
NFASC rs2802808 male CON 0.225 0.483 0.292 0.467 0.533  0.857 0.197 0.201  0.792 
 
 
 
SCZ 0.258 0.533 0.208 0.525 0.475  0.595 
  
(0.553-1.133) 
  
female CON 0.325 0.446 0.229 0.548 0.452  0.257 0.044 0.034  1.417 
      SCZ 0.236 0.450 0.314 0.461 0.539  0.322      (1.026-1.959) 
ITGA8 rs2298033 male CON 0.793 0.207 0.000 0.897 0.103  0.502 0.239 0.263 0.698 
 
 
 
SCZ 0.851 0.149 0.000 0.926 0.074  1.000 
  
(0.370-1.315) 
  
female CON 0.737 0.244 0.019 0.859 0.141  1.000 0.010 0.011  0.500 
      SCZ 0.848 0.152 0.000 0.924 0.076  0.845      (0.292-0.857) 
a
 SNP single nucleotide polymorphisms, SNP identification number and position are determined by NCBI dbSNP 
(http://www.ncbi.nlm.nih.gov/sites/entrez?db=snp); 
b
 Phenotype, CON control, SCZ schizophrenia; 
c
 M Major allele, m minor allele; 
d
 HWE  
Hardy Weinberg equilibrium; 
e
 Genotypic p value, determined with Cochran Armitage test for trend; 
f
 allelic p value, determined with Chi square 
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Table 3 Associations of missense mutations in NFASC and ITGA8 genes with schizophrenia in the second batch of the sample (n control 
710, schizophrenia 567) and the replication sample (n control = 639, schizophrenia = 635) 
Gene SNPs 
a 
Phen 
b Genotype 
c 
Allele 
c 
 p values Odds ratio 
(95% CI) 
Power 
MM Mm mm M m  HWE 
d 
gen 
e
 allelic 
f 
Kobe samples 
      
 
 
  
 
 
NFASC rs2802808 CON 0.278 0.486 0.236 0.521 0.479  0.535 0.694 0.691 0.968 0.059 
   
SCZ 0.285 0.488 0.227 0.529 0.471  0.673   
 
(0.813-1.154)  
  
male CON 0.267 0.494 0.239 0.514 0.486  0.901 0.177 0.180 0.855  
   
SCZ 0.297 0.511 0.192 0.553 0.447  0.690 
  
(0.717-1.019)  
  
female CON 0.288 0.479 0.233 0.527 0.473  0.515 0.426 0.414 1.096  
   
SCZ 0.272 0.463 0.265 0.504 0.496  0.275     (0.920-1.307)  
ITGA8 rs2298033 CON 0.754 0.235 0.012 0.871 0.129  0.311 0.0086 0.010 0.717 0.440 
   
SCZ 0.812 0.185 0.004 0.904 0.096  0.202    (0.021) (0.556-0.926)  
  
male CON 0.765 0.232 0.003 0.881 0.119  0.077 0.274 0.302 0.823  
   
SCZ 0.799 0.201 0.000 0.900 0.100  0.088 
  
(0.621-1.090)  
  
female CON 0.743 0.238 0.019 0.862 0.138  1.000 0.0115 0.0114 0.625  
   
SCZ 0.825 0.167 0.008 0.909 0.091  1.000    (0.0287) (0.472-0.828)  
Niigata samples 
      
 
 
  
 
 
NFASC rs2802808 CON 0.255 0.519 0.225 0.515 0.485  0.532 0.772 0.778 1.022 0.055 
   
SCZ 0.243 0.532 0.224 0.509 0.491  0.121 
  
0.877-1.192)  
  
male CON 0.254 0.516 0.230 0.512 0.488  0.637 0.613 0.624 1.054  
   
SCZ 0.227 0.544 0.230 0.499 0.501  0.109 
  
(0.853-1.304)  
  
female CON 0.257 0.523 0.221 0.518 0.482  0.790 0.884 0.886 0.984  
   
SCZ 0.263 0.519 0.218 0.522 0.478  0.678 
  
(0.788-1.229)  
ITGA8 rs2298033 CON 0.779 0.206 0.016 0.881 0.119  0.791 0.131 0.128 0.823 0.191 
   
SCZ 0.812 0.177 0.011 0.900 0.100  0.869 
  
(0.641-1.058  
 
 
male CON 0.792 0.196 0.012 0.890 0.110  1.000 0.640 0.634 0.920  
   
SCZ 0.813 0.169 0.017 0.898 0.102  0.247 
  
(0.652-1.298)  
2
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female CON 0.764 0.216 0.020 0.872 0.128  0.692 0.087 0.089 0.728  
   
SCZ 0.810 0.187 0.003 0.903 0.097   0.448     (0.505-1.050)   
Combined 
      
 
  
  
 
NFASC rs2802808 CON 0.266 0.499 0.235 0.515 0.485  1.000 0.666 0.668 1.028 0.058 
   
SCZ 0.250 0.517 0.233 0.509 0.491  0.425 
  
(0.906-1.166)  
  
male CON 0.268 0.503 0.229 0.519 0.481  0.848 0.955 0.956 1.005  
   
SCZ 0.244 0.547 0.208 0.518 0.482  0.136 
  
(0.844-1.197)  
  
female CON 0.264 0.495 0.241 0.511 0.489  0.829 0.565 0.561 1.056  
   
SCZ 0.257 0.482 0.261 0.498 0.502  0.726 
  
(0.880-1.266)  
ITGA8 rs2298033 CON 0.766 0.221 0.014 0.876 0.124  0.645 0.0032 0.0035 0.767 0.541 
   
SCZ 0.812 0.181 0.008 0.902 0.098  0.575 
 
(0.0069) (0.642-0.917)  
  
male CON 0.779 0.214 0.007 0.886 0.114  0.212 0.276 0.284 0.873  
   
SCZ 0.807 0.183 0.010 0.899 0.101  1.000 
  
(0.680-1.120)  
  
female CON 0.752 0.228 0.020 0.866 0.134  0.785 0.0024 0.0025 0.674  
   
SCZ 0.817 0.178 0.005 0.906 0.094   0.518   (0.0052) (0.521-0.871)   
a
 SNP single nucleotide polymorphisms, SNP identification number and position are determined by NCBI dbSNP 
(http://www.ncbi.nlm.nih.gov/sites/entrez?db=snp); 
b
 Phenotype, CON control, SCZ schizophrenia; 
c
 M Major allele, m minor allele;  
d
 HWE Hardy Weinberg equilibrium; 
e
 Genotypic p value, determined with Cochran Armitage test for trend; 
f
 allelic p value, determined with Chi square, 
correction for multiple comparisons in parentheses 
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Supplementary figure 1. Experimentally derived cell adhesion molecules (CAMs) pathways map 
in the neural system reported in the Kyoto Encyclopedia of Genes and Genomes. Genes 
examined in this study are highlighted  (http://www.kegg.jp/kegg/pathway/hsa/hsa04514.html). 
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Supplementary figure 2. Haplotype block containing rs2298033 (red box) of the ITGA8 gene 
created using genotype data from Hapmap (release #27) in JPT population. List of the SNPs in 
the block is provided in supplementary table 2. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Supplementary figure 2. Haplotype block containing rs2298033 of the ITGA8 gene constructed 
based on genotype data of the JPT population in Hapmap (release #27) 
(http://hapmap.ncbi.nlm.nih.gov/cgi-perl/gbrowse/hapmap27_B36/) 
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Supplementary Table 1. Missense mutations in cell adhesion molecules genes based on the KEGG pathway map analysis in the Japanese 
population 
Gene name 
Stran
d 
Chr 
Gen build 
Assembly 
rs number Function 
Chr  
Position 
Cont    
Position 
mRNA allele 
change 
Protein 
change 
(fwd) Genotype 
freqency 
allele        
freqency 
CADM1 - 11 37.1 rs74750431 missense 115049423 18611839 GTG→GGG Val→Gly   A           C 
(IGSF4)     GRCh37           356   0.852 0.148 
        rs74751890 
cds-
synon 
115085422 18647838 ATC→ATA Ile→Ile   G            T 
                  300   0.989 0.011 
        rs45525440 missense 115085467 18647883 GAT→GAG Asp→Glu    A            C 
                  285   0.989 0.011 
 CADM3 + 1 37.1 rs862999 
cds-
synon 
159169641 10658283 CTT→CTC Leu→Leu C/C     C/T  C           T 
(IGSF4B)     GRCh37           351 0.841 0.159 0.920  0.080 
NRCAM － 7 37.1 rs401433 
cds-
synon 
107824889 45857732 GCG→GCC Ala→Ala C/C     C/G  C          G 
      GRCh37           735 0.795 0.205 0.898   0.102 
        rs6958498 missense 107834613 45867456 CCT→GCT Pro→Ala C/C     C/G C           G 
                  545 0.727  0.273 0.864   0.136 
        rs404287 
cds-
synon 
107834734 45867577 GCG→GCA Ala→Ala C/T       T/T C            T 
                  534 0.267   0.733 0.133 0.867 
        rs381318 
cds-
synon 
107838464 45871307 GTC→GTA Val→Val A/A    A/C A            C 
                  429 0.721 0.279 0.860 0.140 
        rs1269621 
cds-
synon 
107849908 45882751 AAC→AAT Asn→Asn A/A  A/G  G/G A           G 
                  344 0.455 0.500 0.045 0.705 0.295 
        rs2072546 
cds-
synon 
107872816 45905659 AAC→AAT Asn→Asn A/A    A/G   G/G A           G 
26 
 
                  127 0.267 0.444 0.289 0.489 0.511 
NCAM + 11 37.1 rs584427 
cds-
synon 
113103996 1666412 GTT→GTG Val→Val A/A    A/C    C/C A          C 
      GRCh37           540 0.114 0.341 0.545 0.284 0.76 
L1CAM - X 37.1 rs2071643 
cds-
synon 
153132261 4050199 GGG→GGA Gly→Gly A/A A/G G/G A         G 
      GRCh37           758 0.068 0.023 0.909 0.080 0.920 
CNTN1 + 12 37.1 rs935105 
cds-
synon 
41330611 3473917 AAT→AAC Asn→Asn A/A    A/G   G/G A        G 
      GRCh37           338 0.933 0.044 0.022 0.956 0.044 
        rs1056019 
cds-
synon 
41337435 3480741 AAC→AAT Asn→Asn C/C    C/T    T/T C          T 
                  472 0.311 0.467 0.222 0.544 0.456 
        rs11553341 missense 41414190 3557496 GAG→GGG Glu→Gly A/A    A/G A          G 
                  824 0.977 0.023 0.989 0.011 
CNTN2 + 1 37.1 rs75898472 missense 205022315 56510957 ATG→AGG Met→Arg   G           T 
(axonal)     GRCh37           1   0.023 0.977 
        rs9787172 
cds-
synon 
205027390 56516032 AAC→AAT Asn→Asn C/C    C/T    T/T C           T 
                  99 0.933 0.044 0.022 0.956 0.044 
        rs2275697 missense 205027737 56516379 GCT→ACT Ala→Thr C/C      C/T    T/T C           T 
                  145 0.256 0.488 0.256 0.500 0.500 
        rs2305276 missense 205035721 5624363 CGG→TGG Arg→Trp A/G G/G A          G 
                  657 0.027 0.973 0.014 0.986 
        rs2229868 
cds-
synon 
205041158 56529800 AGC→AGT Ser→Ser C/C     C/T    T/T C          T 
                  876 0.111 0.556 0.333 0.389 0.611 
        rs17416074 missense 205042840 56531482 GTC→ATC Val→Ile A/G G/G A         G 
                  1024 0.022 0.978 0.011 0.989 
NRXN1 － 2 37.1 rs75575150 
cds-
synon 
50765701 29587588 GAT→GAC Asp→Asp   A            G 
      GRCh37           651   0.977 0.023 
27 
 
        rs2303298 
cds-
synon 
50850686 29672573 CCC→CCT Pro→Pro A/A     A/G   G/G A            G 
                  333 0.022 0.333 0.644 0.189 0.811 
NRXN2 － 11 37.1 rs3825074  
cds-
synon 
64415767 9721562 GGC→GGT Gly→Gly C/C C/T T/T C            T 
      GRCh37           1109 0.556 0.378 0.067  0.744 0.256  
        rs526338 
cds-
synon 
64418900 9724695 ATC→ATT Ile→Ile   A           G 
                  915   0.239 0.761 
         rs2285341  
cds-
synon 
64453268 9759063 GCC→GCT Ala→Ala A/G G/G A           G 
                  334 0.091 0.909  0.045 0.955  
NRXN3 + 14 37.1 none               
      GRCh37                 
CNTNAP1 + 17 37.1 rs2271029 
cds-
synon 
40835922 6110074 AGA→CGA Arg→Arg A/A     A/C    C/C A           C 
(NRXN4)     GRCh37           51 0.310 0.500 0.190 0.560 0.440 
        rs77725092 
cds-
synon 
40849573 6123725 GAG→GAA Glu→Glu   A           G 
                  1190   0.034 0.966 
CNTNAP2 ＋ 7 37.1 rs2286128 
cds-
synon 
147183066 7778689 TCG→TCA Ser→Ser C/C     C/T C          T 
(NRXN4)     GRCh37           570 0.889 0.111  0.944 0.056  
        rs74354654 
cds-
synon 
147600748 8196371 TGC→TGT Cys→Cys   C           T 
                  730   0.977 0.023 
        rs10240503 
cds-
synon 
147674978 8270610 TCA→TCG Ser→Ser A/A   A/G   G/G A          G 
                  760 0.489 0.467 0.044  0.722 0.278  
        rs75688908 
cds-
synon 
147869455 8465078 GGC→GGA Gly→Gly   A            C 
                  965   0.023 0.977 
        rs9648691     
cds-
synon 
148106490 8702113 GCC→GCA Ala→Ala A/A A/G G/G A           G 
28 
 
                  1241 0.136 0.364 0.500  0.318 0.682  
NLGN1 + 3 37.1 rs74718952 
cds-
synon 
173993151 80488297 CTC→CTT Leu→Leu   C T 
      GRCh37           231   0.989 0.011 
        rs7646919 
cds-
synon 
173997153 80492299 AAG→AAA Lys→Lys A/G     G/G A          G 
                  454 0.159 0.841 0.080 0.920 
 
      rs16858840 
cds-
synon 
173998955 80494101 CCC→CCT Pro→Pro   C            T 
                  778   0.977 0.023 
NLGN2 + 17 37.1 rs74879880 missense 7318307 6921681 ACC→CCC Thr→Pro   A            C 
      GRCh37           293   0.818 0.182 
        rs224123 
cds-
synon 
7318396 6921770 AGC→AGT Ser→Ser A/A    A/G    G/G A            G 
                  322 0.889 0.089 0.022 0.933 0.067 
        rs12947017 
cds-
synon 
7318935 6922309 GGC→GGT Gly→Gly   C            T 
                  381   0.932 0.068 
NLGN3 + X 37.1 none               
      GRCh37                 
NLGN4X - X 37.1 rs7049300 
cds-
synon 
5821786 3703548 ACC→ACT Thr→Thr A/A     A/G     G/G A            G 
      GRCh37           311 0.111 0.089 0.800 0.156 0.844 
NLGN4Y + Y 37.1 none               
      GRCh37                 
NEGR1 - 1 37.1 rs3795696 
cds-
synon 
72058543 42030461 GCT→GCA Ala→Ala A/A      A/T    T/T A           T 
      GRCh37           299 0.689 0.289 0.022 0.833 0.167 
        rs1413368 
cds-
synon 
72058552 42030470 ACC→ACT Thr→Thr A/A    A/G     G/G A          G 
                  296 0.578 0.400 0.022 0.778 0.222 
NFASC + 1 37.1 rs3795564 missense 204924020 56412662 ACG→ATG Thr→Met A/G    G/G A         G 
29 
 
      GRCh37           159 0.023 0.977 0.011 0.989 
        rs2246662 
cds-
synon 
204943947 56432589 GTC→GTA Val→Val G/G    G/T     T/T G           T 
                  518 0.044 0.356 0.600  0.222 0.778  
        rs6667532 
cds-
synon 
204948659 56437301 CCA→CCG Pro→Pro A/A      A/G A           G 
                  716 0.978 0.022 0.989 0.011  
        rs2802808 missense 204966428 56455070 ATC→ATG Ile→Met C/C     C/G     G/G C           G 
                  971 0.205 0.500 0.295  0.455 0.545  
        rs4951151    
cds-
synon 
204970302 56458944 CCT→CCC Pro→Pro C/C      C/T    T/T C          T 
                  1008 0.023 0.273 0.705  0.159 0.841  
CDH2 - 18 37.1 rs2289664 missense 25532304 7021406 AAT→AGT Asn→Ser C/T     T/T C           T 
      GRCh37           845 0.067 0.933 0.033 0.967 
        rs1041985 
cds-
synon 
25543387 7032489 GCC→GCT Ala→Ala C/C     C/T     T/T C           T 
                  816 0.372 0.442 0.186 0.593 0.407 
 
      rs17857112 missense 25570299 7059401 ACA→GCA Thr→Ala C/C      T/T C           T 
                  454 0.023 0.977 0.023 0.977 
        rs1041970 missense 25589796 7078898 AGT→ACT Ser→Thr C/G    G/G C           G 
                  196 0.023 0.977 0.012 0.988 
        rs17445840 missense 25593694 7082796 GCA→ACA Ala→Thr C/C     C/T C           T 
                  118 0.756 0.244 0.878 0.122 
CSPG2 + 5 37.1 rs12332199 
cds-
synon 
82786194 33380553 ACT→ACC Thr→Thr C/C    C/T    T/T C           T 
(VCAN)     GRCh37           116 0.067 0.311 0.622  0.222 0.778  
        rs35042106 
cds-
synon 
82786239 33380598 GAC→GAT Asp→Asp   C            T 
                  131   0.852 0.148 
        rs4470745 
cds-
synon 
82789647 33384006 GTA→GTG Val→Val A/A     A/G A          G 
                  215 0.867 0.133  0.933 0.067  
30 
 
        rs2652098 missense 82808072 33402431 TCG→TTG Ser→Leu A/G    G/G A           G 
                  300 0.341 0.659  0.170 0.830  
        rs2287926 missense 82815408 33409767 GGC→GAC Gly→Asp A/A     A/G   G/G A           G 
                  428 0.022 0.289 0.689  0.167 0.833  
        rs2548541 
cds-
synon 
82833145 33427504 CAG→CAA Gln→Gln A/A   A/G    G/G A           G 
                  1441 0.467 0.422 0.111  0.678 0.322  
        rs309559 missense 82833369 33427728 AAA→AGA Lys→Arg C/C     C/T    T/T C           T 
                  1516 0.159 0.614  0.227  0.466  0.534  
        rs188703 missense 82834299 33428658 CGT→CAT Arg→His C/C     C/T   T/T C           T 
                  1826 0.341 0.545 0.114  0.614 0.386  
        rs309557 
cds-
synon 
82834630 33428989 GGT→GGC Gly→Gly A/A     A/G   G/G A           G 
                  1936 0.227 0.614 0.159  0.534 0.466  
        rs160279 
cds-
synon 
82835545 33429904 AGA→AGG Arg→Arg   C            T 
                  2241   0.450  0.550  
        rs160278 missense 82835724 33430083 TTT→TAT Phe→Tyr A/A     A/T    T/T A            T 
 
                2301 0.227 0.614 0.159  0.534 0.466  
        rs3734094 
cds-
synon 
82835765 33430124 GTA→CTA Val→Leu C/C     C/G C          G 
                  2315 0.844 0.156  0.922 0.078  
        rs76091728 nonsense 82836342 33430701 TCA→TAA Ser→OCH   A           C 
                  2507   0.011 0.989 
        rs75771891 
cds-
synon 
82836565 33430924 GAT→GAC Asp→Asp   C           T 
                  2581   0.114 0.886 
        rs160277 missense 82837631 33431990 GAT→TAT Asp→Tyr A/A     A/C     C/C A            C 
                  2937 0.116 0.535  0.349  0.384 0.616  
SDC1 - 2 37.1 rs2230924 
cds-
synon 
20403949 4074225 GAG→GAA Glu→Glu   A           G 
(SDC)     GRCh37           84   0.239 0.761 
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PVRL1 - 11 37.1 rs76403536 
cds-
synon 
119508832 23071248 ACC→ACT Thr→Thr   A            G 
      GRCh37           451   0.114 0.886 
        rs7940667 missense 119510644 23073060 GTT→GGT Val→Gly A/C     C/C A            C 
                  361 0.156 0.844 0.078 0.922 
PVRL3 + 3 37.1 none               
      GRCh37                 
PTPRF + 1 37.1 rs1065771 
cds-
synon 
44035352 14007270 GCC→GCT Ala→Ala C/C      C/T   T/T C             T 
      GRCh37           157 0.682 0.295 0.023 0.830 0.170 
        rs3748796 missense 44057042 14028960 TAC→TGC Tyr→Cys A/A    A/G A           G 
                  450 0.930 0.070 0.965 0.035 
        rs2304354 
cds-
synon 
44057535 14029453 ATC→ATT Ile→Ile C/C      C/T C          T 
                  528 0.956 0.044 0.978 0.022 
        rs3748800 missense 44058143 14030061 GAC→AAC Asp→Asn A/G G/G A           G 
                  562 0.044 0.956 0.022 0.978 
        rs3828151 
cds-
synon 
44058265 14030183 GCC→GCA Ala→Ala A/A    A/C    C/C A            C 
                  602 0.045 0.386 0.568 0.239 0.761 
        rs631248 
cds-
synon 
44071221 14043139 GTG→GTA Val→Val A/A     A/G    G/G A          G 
                  1137 0.289 0.578 0.133 0.578 0.422 
        rs1065772 
cds-
synon 
44072018 14043936 ACC→ACT Thr→The C/C   C/T    T/T C            T 
                  1197 0.622 0.333 0.044 0.789 0.211 
        rs10890266 
cds-
synon 
44072066 14043984 CCC→CCT Pro→Pro C/C      C/T     T/T C          T 
                  1213 0.622 0.333 0.044 0.789 0.211 
        rs641365 
cds-
synon 
44083507 14055425 GGT→GGC Gly→Gly C/C     C/T     T/T C         T 
 
                1432 0.267 0.578 0.156 0.556 0.444 
        rs1143702 cds- 44086831 14058749 TAC→TAT Tyr→Tyr C/C     C/T    T/T C         T 
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synon 
                  1861 0.227 0.523 0.250 0.489 0.511 
PTPRM + 18 37.1 rs2230601 
cds-
synon 
8069868 8059868 AAC→AAT Asn→Asn C/C     C/T    T/T C          T 
      GRCh37           439 0.465 0.488 0.047 0.709 0.291 
        rs593978 
cds-
synon 
8387195 8377195 GAG→GAA Glu→Glu C/C     C/T     T/T C           T 
                  1390 0.035 0.465 0.500 0.267 0.733 
        rs593950 
cds-
synon 
8387219 8377219 ACG→ACC Thr→Thr C/C     C/G    G/G C          G 
                  1398 0.068 0.295 0.636 0.216 0.784 
ITGAV + 2 37.1 rs3738918 missense 187511466 37720884 ATC→GTC Ile→Val A/A    A/G A          G 
      GRCh37           359 0.907 0.093 0.953 0.047 
        rs2230616 missense 187532417 37741835 ATC→GTC Ile→Val A/A     A/G A          G 
                  737 0.911 0.089 0.956 0.044 
ITGA8 - 10 37.1 rs1041135 missense 15573050 15513050 GCA→GTA Ala→Val C/C      C/T    T/T C           T 
      GRCh37   
 
  
  
994 0.600 0.378 0.022 0.789 0.211 
          
 
  
   
    
                  
 
    
        rs2298033 missense 15649710 15589710 TCC→TTC     Ser→Phe C/C     C/T     T/T C           T 
          
 
  
 
 577 0.800 0.178 0.022 0.889 0.111 
ITGB1 - 10 37.1 rs76211561 missense 33200525 33140525 TTG→TTT Leu→Phe   A           C 
      GRCh37           594   0.034 0.966 
        rs2230396 
cds-
synon 
33209266 33149266 GGC→GGA Gly→Gly A/A     A/C     C/C A           C 
                  392 0.477 0.318 0.364 0.636 0.364 
        rs2230395 
cds-
synon 
33211227 33151227 TGT→TGC Cys→Cys A/A    A/G    G/G A           G 
                  261 0.591 0.318 0.091 0.750 0.250 
        rs2230394 
cds-
synon 
33217110 33157110 TAC→TAT Tyr→Tyr C/C    C/T     T/T C           T 
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                  153 0.489 0.311 0.200 0.644 0.356 
ITGB8 + 7 37.1 rs3735619 
cds-
synon 
20418678 20408678 GCC→GCT Ala→Ala C/C     C/T     T/T C           T 
      GRCh37           131 0.400 0.400 0.200 0.600 0.400 
        rs6968952 
cds-
synon 
20421490 20411490 TAT→TAC Tyr→Tyr C/C     C/T     T/T C            T 
                  314 0.140 0.419 0.442 0.349 0.651 
        rs80015015 missense 20441504 20431504 TGT→TAT Cys→Tyr   A          G 
                  481   0.057 0.943 
 
*   The genes were selected based on the cell adhesion molecule reported in the KEGG (http://www.kegg.jp/kegg/pathway/hsa/hsa04514.html)  
** SNP identification number, position, and frequencies are based on the reported data in the NCBI dbSNP (http://www.ncbi.nlm.nih.gov/sites/entrez?db=snp)  
*** Highlighteds are the selected SNPs for genotypings 
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Supplementary table 2. List of the SNPs in the haplotype block containing rs2298033 of ITGA8 gene 
 
No. SNP position No. SNP position No. SNP position 
1. rs17137512 15676972 22. rs2275619 15690591 43. rs7912597 15709063 
2. rs1057969 15678757 23. rs9333156 15690749 44. rs7076619 15709436 
3. rs3737304 15679417 24. rs9333155 15690790 45. rs10904603 15709749 
4. rs7916993 15679968 25. rs9333154 15690923 46. rs2100303 15711057 
5. rs980712 15680110 26. rs1451666 15692374 47. rs11253584 15711117 
6. rs17137530 15680226 27. rs10737006 15694064 48. rs11253585 15713068 
7. rs1891049 15680366 28. rs896431 15696680 49. rs12414926 15714011 
8. rs1319614 15681034 29. rs7094378 15697459 50. rs1473362 15714141 
9. rs1451667 15681444 30. rs2277203 15698303 51. rs1473361 15714213 
10. rs1037372 15682000 31. rs7099530 15698602 52. rs7082740 15714422 
11. rs6602048 15682615 32. rs7083600 15698665 53. rs10904605 15714770 
12. rs4748182 15683522 33. rs4342920 15698781 54. rs1473360 15715786 
13. rs4748184 15684004 34. rs9333145 15699017 55. rs1542290 15716686 
14. rs4747247 15684236 35. rs7899801 15700439 56. rs12414738 15718422 
15. rs4747248 15684396 36. rs7092876 15700508 57. rs11253587 15718696 
16. rs1319475 15685759 37. rs11253579 15702014 58. rs1376690 15720079 
17. rs2282384 15688110 38. rs10508490 15702543 59. rs1451665 15722433 
18. rs2282383 15688249 39. rs1037375 15704458 60. rs1451664 15722545 
19. rs2044892 15688654 40. rs7079006 15705060 61. rs7072090 15725019 
20. rs2298033 15689716 41. rs2039908 15706485 
   21. rs2298032 15690005 42. rs10795312 15707285       
 
 
